Please Wait.....
Report
2025 Diagnostics Research Review
Market Research Report I 2026-04-10 I 277 Pages I BCC Research
Description
Report Scope
The diagnostics industry has grown despite the challenging economic conditions in recent years. The industry draws much attention and scrutiny from the public and government, and is currently undergoing many changes due to increased focus on regulations. These changes can be seen across many countries. The U.S., the largest diagnostics market, is leading the trend with changes intended to make healthcare more affordable. Opportunities for the diagnostics industry are manifold, with the appearance of new markets located mainly in emerging economies with varying needs.
Increasing healthcare expenditures and the growth of emerging economies have increased the demand for technologically better diagnostic devices, kits, reagents, and other accessories. Additionally, the introduction of more stringent regulations, specifically in the developed markets of the U.S. and Europe, has forced diagnostics manufacturers to launch advanced products that include new materials, a focus on in-depth indications, and the ability to produce additional new data.
Some of the major driving factors in the market are the increasing prevalence of chronic and infectious diseases, technological advances in diagnostics, increasing investments in AI in the diagnostics market, increased applications in non-oncology areas, and growing adoption of personalized medicine.
Furthermore, technically sophisticated diagnostics are needed for clinical research, as the market is highly competitive, and companies must continuously reinvent their product portfolios to enter new markets and place themselves as key participants in the healthcare system. There is a shift toward a value-based healthcare market where price and purchase decisions are based on outcomes. This has further led to increased scrutiny of device technology, and consequently, the degree of competition has risen. Some of the major firms in the diagnostics market include Abbott, Medtronic, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, GE Healthcare, Koninklijke Philips N.V., Agilent Technologies Inc., QIAGEN, Danaher Corp., Sysmex, Thermo Fisher Scientific Inc., BD, and others.
The diagnostics industry is a multi-billion-dollar market with an outlook for continued growth in the coming years. Hospital care is growing, and the diagnostics industry is being looked at to provide low-cost technology for home healthcare. Now, the industry seeks healthcare diagnostic devices, kits, and reagents that individuals with unskilled healthcare experience can use. The need for modern technology, equipment, and devices can be leveraged through diagnostic equipment as manufacturers seek to create better-quality healthcare solutions.
The above reasons are compelling enough to analyze and research the diagnostics market, as the market has tremendous growth potential.
It includes highlights from these reports published in 2024:
- MDS051B Tissue Diagnostics: Technologies and Global Markets
- HLC300A Global Colorectal Cancer Screening and Diagnostics Market
- MDS046B Oncology Diagnostics: Global Markets
- BIO150E Liquid Biopsy Research Tools, Services, and Diagnostics
- BIO151B Human Microbiome-based Drugs and Diagnostics
- BIO063F Molecular Diagnostics: Technologies and Global Markets
- HLC186D In Vitro Diagnostics: Technologies and Global Markets
- PHM026D Global Markets for Allergy Diagnostics and Treatments
- HLC197B Noninvasive Cancer Diagnostics: Technologies and Global Markets
- HLC029G Global Markets for Diabetes Therapeutics and Diagnostics
After you survey the excerpts in this Research Review, we encourage you to follow up on these topics by checking out the full market research reports associated with each topic. BCC Research looks forward to serving your market intelligence needs in the future.
Executive Summary
Summary:
The global market for human microbiome-based drugs and diagnostics was valued at $315.2 million in 2024 and is expected to reach $1.2 billion by the end of 2030, at a CAGR of 25.6% from 2025 to 2030.
The global market for molecular diagnostics was valued at $20.3 billion in 2024 and is expected to reach $42.6 billion by the end of 2030, at a CAGR of 13.1% from 2025 to 2030.
The global market for noninvasive cancer diagnostics was valued at $112.8 billion in 2024 and is projected to reach $165.2 billion by the end of 2030, at a CAGR of 6.6% from 2025 to 2030.
Table of Contents
Chapter 1 Foreword
Research Review Scope
Chapter 2 Tissue Diagnostics: Technologies and Global Markets (MDS051B)
Market Outlook
Scope of Report
Market Summary
Market Overview and Definitions
Immunohistochemistry (IHC)
In Situ Hybridization
Polymerase Chain Reaction
Next-Generation Sequencing
General Culture Testing
Market Dynamics
Market Drivers
Market Opportunities
Market Restraints
Market Challenges
Emerging Technologies and Developments
Market Breakdown
Market Breakdown by Product Type
Market Breakdown by Segment
Histopathology Market
Molecular Pathology Market
Microbiology Testing Market
Digital Pathology Market
Market Breakdown by Region
North America
Europe
Asia-Pacific
Latin America
Rest of the World
Sustainability in the Market for Tissue Diagnostics: An ESG Perspective
Introduction to ESG
Environmental Performance
Social Performance
Governance Performance
Concluding Remarks from BCC
Chapter 3 Global Colorectal Cancer Screening and Diagnostics Market (HLC300A)
Market Outlook
Scope of Report
Market Insights
Market Overview
Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Emerging Technologies
Global Market for Colorectal Cancer Screening and Diagnostic Testing Services
Market Analysis by Test Type
Colonoscopy and Sigmoidoscopy Tests
Stool DNA Tests
Blood-Based/Biomarker Tests
Fecal Occult Blood Tests (FOBT)
Fecal Immunochemical Tests (FIT)
Market Analysis by Region
North America
Europe
Asia-Pacific
Rest of the World
Sustainability in the Colorectal Cancer Screening and Diagnostic Testing Service Market
Introduction
Sustainability
Concluding Remarks from BCC
Chapter 4 Oncology Diagnostics: Global Markets (MDS046B)
Market Outlook
Scope of Report
Market Summary
Market Dynamics and Growth Factors
Emerging Technologies
Segmental Analysis
Regional Analysis
Strategic Initiatives
Conclusion
Market Overview
Market Dynamics
Market Drivers
Market Opportunities
Market Restraints
Market Challenges
Emerging Technologies
Global Market Insights
Market Breakdown by Product Type
Diagnostics Imaging
Endoscopy Devices
Tumor Biomarker Tests
Biopsy Devices
Hematoxylin and Eosin
Immunohistochemistry
In situ Hybridization
Polymerase Chain Reaction
Next-Generation Sequencing
Others
Market Breakdown by Region
Key Takeaways
North America
Europe
Asia-Pacific
South America
Middle East and Africa (MEA)
Sustainability in the Market for Oncology Diagnostics: An ESG Perspective
Introduction to ESG
ESG Performance Analysis
Concluding Remarks from BCC
Chapter 5 Liquid Biopsy Research Tools, Services and Diagnostics (BIO150E)
Market Outlook
Scope of Report
Market Summary
Market Overview
Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Emerging Technologies
Market Trends
Global Market for Liquid Biopsy by Application
Non-invasive Prenatal Testing (NIPT)
Cancer
Organ Transplantation
Global Market for Liquid Biopsy by Region
North America
Europe
Asia-Pacific
Rest of the World (RoW)
Sustainability in the Liquid Biopsy Market: ESG Perspective
Introduction to ESG
ESG Practices in the Liquid Biopsy Industry
Environmental Performance
Social Performance
Governance Performance
ESG Risk Ratings
Concluding Remarks from BCC Research
Chapter 6 Human Microbiome-based Drugs and Diagnostics (BIO151B)
Market Outlook
Scope of Report
Market Summary
Market Dynamics
Emerging Technologies
Analysis by Segment
Regional Analysis
Conclusion
Overview and Market Definition
Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Emerging Technologies
Market Analysis by Type
Microbiome-based Drugs
Microbiome-based Diagnostics
Market Analysis by Region
North America
Europe
Asia-Pacific
South America
Middle East and Africa
Sustainability in the Human Microbiome-based Drugs and Diagnostics Industry: An ESG Perspective
Introduction to ESG
ESG Risk Ratings
Concluding Remarks
Chapter 7 Molecular Diagnostics: Technologies and Global Markets (BIO063F)
Market Outlook
Scope of Report
Market Summary
Market Dynamics and Growth Factors
Emerging Technologies
Segmental Analysis
Regional Analysis
Conclusion
Market Overview
Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Emerging Technologies
Market Analysis by Technology
Key Takeaways
Polymerase Chain Reaction (PCR)
Next-Generation Sequencing (NGS)
In Situ Hybridization
Microarrays
Others
Market Analysis by Product and Service
Key Takeaways
Consumables
Instruments
Software and Services
Market Analysis by Region
Key Takeaways
North America
Europe
Asia-Pacific
Rest of the World
Sustainability in the Molecular Diagnostics Market: An ESG Perspective
Introduction to ESG
ESG Practices in the Molecular Diagnostics Industry
ESG Risk Ratings
Conclusion
Chapter 8 In Vitro Diagnostics: Technologies and Global Markets (HLC186D)
Market Outlook
Scope of Report
Market Summary
Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Emerging Technologies in the IVD Market
Market Analysis by Technology
Immunochemistry
POC Testing
Hematology
Molecular Diagnostics
Tissue Diagnostics
Clinical Microbiology
Market Analysis by Region
North America
Europe
Asia-Pacific
Latin America
Middle East and Africa
Sustainability in the In Vitro Diagnostics Industry: An ESG Perspective
Importance of ESG in In Vitro Diagnostics Manufacturing Industry
ESG Practices in the In Vitro Diagnostics Industry
Environmental Performance
Social Performance
Governance Performance
Company Role in ESG Development
ESG Risk Ratings
BCC Research Viewpoint
Chapter 9 Global Markets for Allergy Diagnostics and Treatments (PHM026D)
Market Outlook
Scope of Report
Market Summary
Market Dynamics and Growth Factors
Segmental Analysis
Regional Analysis
Conclusion
Market Overview
Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Emerging Technologies
Global Allergy Diagnostics and Treatment Market by Type
Key Takeaways
Diagnostics
Treatments
Global Allergy Diagnostics and Treatment Market by Drug Type
Key Takeaways
Prescription Drugs
Over-the-Counter Drugs
Global Allergy Diagnostics and Treatment Market by Region
Key Takeaways
North America
Europe
Asia-Pacific
Middle East and Africa (MEA)
South America
Sustainability in the Allergy Diagnostics and Treatment Market:ESG Perspective
Introduction to ESG
Role of ESG in the Allergy Diagnostics and Treatment Market
ESG Risk Ratings
Conclusion
Chapter 10 Noninvasive Cancer Diagnostics: Technologies and Global Markets (HLC197B)
Market Outlook
Scope of the Report
Market Summary
Market Dynamics and Growth Factors
Emerging Technologies
Segmental Analysis
Regional Analysis
Conclusion
Current Market Overview
Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Market Challenges
Emerging Technologies
Market Analysis by Cancer Type
Key Takeaways
Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Cervical Cancer
Stomach Cancer
Liver Cancer
Esophageal Cancer
Bladder Cancer
All Other Cancers
Market Analysis by Technology Type
Key Takeaways
Diagnostic Imaging Technologies
Advanced Noninvasive Approaches
Conventional Noninvasive Cancer Screening, Diagnostic Assays and Tests
Market Analysis by Region
Key Takeaways
North America
Europe
Asia-Pacific
South America
Middle East and Africa
Sustainability in Global Noninvasive Cancer Diagnostics Market: An ESG Perspective
Introduction to ESG
Major Manufacturers: ESG Efforts
Concluding Remarks from BCC Research
Chapter 11 Global Markets for Diabetes Therapeutics and Diagnostics (HLC029G)
Market Outlook
Scope of Report
Market Summary
Overview
Current Market Scenario
Segmental Analysis
Technological Advances
Conclusion
Market Overview
Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Market Challenges
Emerging Technologies
Global Diabetes Therapeutics and Diagnostic Market by Product
Key Takeaways
Diabetes Therapeutics
Diabetes Monitoring Devices and Accessories
Insulin Delivery Devices
Global Diabetes Therapeutics and Diagnostic Market by Region
Key Takeaways
North America
Europe
Asia-Pacific
Middle East and Africa
South America
Sustainability in the Diabetes Therapeutics and Diagnostics Market: An ESG Perspective
Introduction to ESG
ESG in Diabetes Therapeutics and Diagnostics
ESG Performance Analysis
Concluding Remarks from BCC
Chapter 12 Appendix
Methodology
Analysts Credentials
List of Tables
Table 1 : Global Tissue Diagnostics Market, by Product Type, Through 2029
Table 2 : Global Incidence of All Cancers, by Region, 2022-2045
Table 3 : Cancer Cases, by Country, 2022
Table 4 : Incidence of Cancer, by Cancer Type, 2022
Table 5 : Global Tissue Diagnostics Market, Through 2029
Table 6 : Global Tissue Diagnostics Market, by Product Type, Through 2029
Table 7 : Global Tissue Diagnostics Market, by Segment Type, Through 2029
Table 8 : Global Tissue Diagnostics Market, by Region, Through 2029
Table 9 : ESG: Environmental Overview
Table 10 : ESG: Social Overview
Table 11 : ESG: Governance Overview
Table 12 : Global Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Region, Through 2029
Table 13 : Countries with Highest Colorectal Cancer Incidence and Rates, 2022
Table 14 : Successful Colorectal Cancer Screening Initiatives, 2004-2011
Table 15 : Global Market for Colorectal Cancer Screening and Diagnostic Testing Services, Through 2029
Table 16 : Global Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Test Type, Through 2029
Table 17 : Global Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Region, Through 2029
Table 18 : Recent ESG Highlights from Select Testing Services Providing Companies
Table 19 : ESG Rankings for a Few Service-Providing Companies, 2024
Table 20 : ESG Rankings for Major Product Manufacturing Companies, 2024
Table 21 : Global Market for Oncology Diagnostics, by Product Type, Through 2029
Table 22 : Cancer Treatments Based on Specific Tests
Table 23 : Select FDA-Approved AI-Associated/Associable-Equipped Medical Devices
Table 24 : Global Oncology Diagnostics Market, by Product Type, Through 2029
Table 25 : Global Oncology Diagnostics Market, by Region, Through 2029
Table 26 : ESG: Environmental Overview
Table 27 : ESG: Social Overview
Table 28 : ESG: Governance Overview
Table 29 : Global Market for Liquid Biopsy, by Region, Through 2029
Table 30 : Liquid Biopsy Sample Types and Characteristics
Table 31 : Global Market for Liquid Biopsy, by Application, Through 2029
Table 32 : Global Market for Liquid Biopsy, by Region, Through 2029
Table 33 : Key Focus Areas in ESG Metrics
Table 34 : Environmental Performance Initiatives in the Liquid Biopsy Market
Table 35 : Social Performance Initiatives in the Liquid Biopsy Market
Table 36 : Governance Performance Initiatives in the Liquid Biopsy Market
Table 37 : ESG Rankings for Leaders in the Market for Liquid Biopsy, 2024*
Table 38 : Global Market for Human Microbiome-based Drugs and Diagnostics, by Region, Through 2030
Table 39 : Diseases Associated with Microbiome Dysbiosis
Table 40 : Global Market for Human Microbiome-based Drugs and Diagnostics, by Type, Through 2030
Table 41 : Global Market for Human Microbiome-based Drugs and Diagnostics, by Region, Through 2030
Table 42 : ESG Goals of Human Microbiome-based Drugs and Diagnostics Companies
Table 43 : ESG Risk Ratings for Human Microbiome-based Drugs and Diagnostics Firms, 2025
Table 44 : Global Molecular Diagnostics Market, by Region, Through 2030
Table 45 : Global Molecular Diagnostics Market, by Technology, Through 2030
Table 46 : Global Molecular Diagnostics Market, by Product and Service, Through 2030
Table 47 : Global Molecular Diagnostics Market, by Region, Through 2030
Table 48 : Environmental Performance Initiatives in the Molecular Diagnostics Market
Table 49 : Social Performance Initiatives in the Molecular Diagnostics Market
Table 50 : Governance Performance Initiatives in the Molecular Diagnostics Market
Table 51 : ESG Risk Rankings for Molecular Diagnostics Companies, 2025
Table 52 : Global Market for In Vitro Diagnostics, by Region, Through 2029
Table 53 : Global Market for In Vitro Diagnostics, by Technology, Through 2029
Table 54 : Summary of Electrochemiluminescence POCT Devices with Their Analytic Performance
Table 55 : Global Market for In Vitro Diagnostics, by Region, Through 2029
Table 56 : ESG Practices: Environmental Performance
Table 57 : ESG Practices: Social Performance
Table 58 : ESG Practices: Governance Performance
Table 59 : Creating an Attractive Workplace: Social Performance
Table 60 : ESG Rankings for Leading In Vitro Diagnostics Companies, 2023 and 2024*
Table 61 : Global Market for Allergy Diagnostics and Treatment, by Region, Through 2030
Table 62 : Global Market for Allergy Diagnostics and Treatment, by Type, Through 2030
Table 63 : Global Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
Table 64 : Global Market for Allergy Diagnostics and Treatment, by Region, Through 2030
Table 65 : ESG Risk Rankings for Allergy Diagnostic and Treatment Market Companies, 2025*
Table 66 : Global Market for Noninvasive Cancer Diagnostics, by Region, Through 2030
Table 67 : Types of Liquid Biopsy and Their Clinical Applications, 2024
Table 68 : Estimated Cancer Incidence, Age (0-85+), 2022-2045
Table 69 : Estimated Cancer Incidence in Males in the U.S., by Cancer Site, 2025
Table 70 : Estimated Cancer Incidence in Females in the U.S., by Cancer Site, 2025
Table 71 : Global Market for Noninvasive Cancer Diagnostics, by Cancer Type, Through 2030
Table 72 : Global Market for Noninvasive Cancer Diagnostics, by Technology Type, Through 2030
Table 73 : Global Market for Noninvasive Cancer Diagnostics, by Region, Through 2030
Table 74 : ESG Highlights, by Major Players, 2024
Table 75 : Global Market for Diabetes Therapeutics and Diagnostics, by Region, Through 2030
Table 76 : Indonesia: Price Ranges of Diabetes Monitoring Products, by Sector, 2024
Table 77 : Selected Technology Integrated Products
Table 78 : Global Market for Diabetes Therapeutics and Diagnostics, by Product, Through 2030
Table 79 : Global Revenues of Leading Diabetes-Focused Pharmaceutical Companies,2023 and 2024
Table 80 : Major Companies: Diabetes Therapeutic Pipeline
Table 81 : Insulin vs. GLP-1 Therapy
Table 82 : Standard GLP-1 RAs vs. Dual/Triple Agonists
Table 83 : Comparison of Different Types of Insulins
Table 84 : Oral Antidiabetic Drugs Overview
Table 85 : Blood Glucose Test Strips, by Manufacturer
Table 86 : Blood Glucose Meters, by Manufacturer
Table 87 : Continuous Glucose Monitoring Systems, by Manufacturer
Table 88 : Comparison of Continuous Glucose Monitoring Systems, by Company
Table 89 : Lancets and Lancet Devices, by Manufacturer
Table 90 : Insulin Infusion Pumps, by Manufacturer
Table 91 : Insulin Pen, by Manufacturer
Table 92 : Global Market for Diabetes Therapeutics and Diagnostics, by Region, Through 2030
Table 93 : Diabetes Waste Management Recommendations
Table 94 : ESG Rankings for Diabetes Therapeutics and Diagnostics Companies, 2025*
Table 95 : ESG: Environmental Overview
Table 96 : ESG: Social Overview
Table 97 : ESG: Governance Overview
List of Figures
Figure 1 : Shares of Global Market for Tissue Diagnostics, by Product Type, 2023
Figure 2 : Shares of All Cancer Cases, by Region, 2022
Figure 3 : Shares of Global Market for Tissue Diagnostics, by Segment Type, 2023
Figure 4 : Shares of Global Market for Tissue Diagnostics, by Region, 2023
Figure 5 : ESG Pillars
Figure 6 : Advantages of ESG for Companies
Figure 7 : Global Market Shares of Colorectal Cancer Screening and Diagnostic Testing Services, by Region, 2023
Figure 8 : Global Market Shares of Colorectal Cancer Screening and Diagnostic Testing Services, by Test Type, 2023
Figure 9 : Global Market Shares of Colorectal Cancer Screening and Diagnostic Testing Services, by Region, 2023
Figure 10 : Snapshot of ESG Pillars
Figure 11 : Global Market Shares of Oncology Diagnostics, by Product Type, 2023
Figure 12 : Number of FDA-Approved Companion Diagnostic Devices, 1997-2024
Figure 13 : Share of Global Market for Oncology Diagnostics, by Product Type, 2023
Figure 14 : Share of Global Market for Oncology Diagnostics, by Region, 2023
Figure 15 : ESG Pillars
Figure 16 : Advantages of ESG for Companies
Figure 17 : Global Market Shares of Liquid Biopsy, by Application 2024
Figure 18 : Estimated Number of New Cancer Cases Globally, 2022, 2045 and 2050
Figure 19 : Global Market Shares of Liquid Biopsy, by Region, 2024
Figure 20 : How a Strong ESG Proposition Benefits Businesses?
Figure 21 : Global Market Shares of Human Microbiome-based Drugs and Diagnostics, by Region, 2024
Figure 22 : Diseases and Conditions Associated with Dysbiosis
Figure 23 : Global Market Shares of Human Microbiome-based Drugs and Diagnostics, by Type, 2024
Figure 24 : Global Market Shares of Human Microbiome-based Drugs and Diagnostics, by Region, 2024
Figure 25 : Global Molecular Diagnostics Market Shares, by Region, 2024
Figure 26 : Global Molecular Diagnostics Market Shares, by Technology, 2024
Figure 27 : Global Molecular Diagnostics Market Shares, by Product and Service, 2024
Figure 28 : Global Molecular Diagnostics Market Shares, by Region, 2024
Figure 29 : Key ESG Metrics of Molecular Diagnostics Companies
Figure 30 : Global Market Shares of In Vitro Diagnostics, by Region, 2023
Figure 31 : Emerging AI Applications in In Vitro Diagnostics
Figure 32 : Global Market Shares of In Vitro Diagnostics, by Technology, 2023
Figure 33 : Global Market Shares of In Vitro Diagnostics, by Region, 2023
Figure 34 : SNAPSHOT: Key ESG Trends in the In Vitro Diagnostics Industry
Figure 35 : Global Market Shares of Allergy Diagnostic and Treatments, by Region, 2024
Figure 36 : Global Market Shares of Allergy Diagnostics and Treatment, by Type, 2024
Figure 37 : Global Market Shares of Allergy Diagnostics and Treatment, by Drug Type, 2024
Figure 38 : Global Market Shares of Allergy Diagnostics and Treatment, by Region, 2024
Figure 39 : Pillars of ESG
Figure 40 : Advantages of ESG for Companies
Figure 41 : Global Market Shares for Noninvasive Cancer Diagnostics, by Region, 2024
Figure 42 : Global Market Shares for Noninvasive Cancer Diagnostics, by Cancer Type, 2024
Figure 43 : Global Market Shares for Noninvasive Cancer Diagnostics, by Technology Type, 2024
Figure 44 : Global Market Shares for Noninvasive Cancer Diagnostics, by Region, 2024
Figure 45 : Pillars of Sustainable Cancer Care
Figure 46 : :Global Market Shares for Diabetes Therapeutics and Diagnostics, by Region, 2024
Figure 47 : DIABETES: Type
Figure 48 : Estimated Number of People Aged 20 to 79 With Diabetes, Globally, 2000-2024
Figure 49 : Global Market Shares for Diabetes Therapeutics and Diagnostics, by Product, 2024
Figure 50 : Global Market Shares for Diabetes Therapeutics and Diagnostics, by Region, 2024
Figure 51 : ESG Pillars
Figure 52 : Advantages of ESG for Companies
Figure 53 : Diabetes Therapeutics and Diagnostics: Key ESG Issues
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security